2. Academic Validation
  3. Cancer Drug Discovery 2010: from molecules to medicine

Cancer Drug Discovery 2010: from molecules to medicine

  • Expert Rev Clin Pharmacol. 2010 Sep;3(5):613-5. doi: 10.1586/ecp.10.50.
Keith Jones 1,  Tatiana McHardy
Affiliations

Affiliation

  • 1 Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK. keith.jones@icr.ac.uk.
PMID: 22111742 DOI: 10.1586/ecp.10.50
Abstract

This article provides an overview of a recent 1-day symposium on the current status and the future prospects for small-molecule therapeutics in oncology. Presentations included aspects of kinase inhibition, the targeting of G-quadruplexes, oxygen sensing as a therapeutic target and sulfatase inhibitors for hormone-dependent breast Cancer.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-100600
    ≥98.0%, CDK2 Inhibitor
    CDK